Consistent with the limited biomarker literature, our demonstration of stable CA 15 − 3 and CEA levels, coupled with a small, clinically irrelevant decline in CA 125, reproduces the pattern reported in smaller cohorts of fibroadenoma and adenosis [14–17]. The gene discussed is CEACAM5; the disease is breast adenosis.